Pharmacokinetics and tolerability of exemestane in combination with raloxifene in postmenopausal wom...
Pharmacokinetics and tolerability of exemestane in combination with raloxifene in postmenopausal women with a history of breast cancer
About this item
Full title
Author / Creator
Traina, T. A. , Poggesi, I. , Robson, M. , Asnis, A. , Duncan, B. A. , Heerdt, A. , Dang, C. , Lake, D. , Moasser, M. , Panageas, K. , Borgen, P. , Norton, L. , Hudis, C. and Dickler, M. N.
Publisher
Boston: Springer US
Journal title
Language
English
Formats
Publication information
Publisher
Boston: Springer US
Subjects
More information
Scope and Contents
Contents
Purpose:
Raloxifene is a second-generation selective estrogen receptor modulator that reduces the incidence of breast cancer in postmenopausal women. Exemestane, a steroidal aromatase inhibitor, decreases contralateral new breast cancers in postmenopausal women when taken in the adjuvant setting. Preclinical evidence suggests a rationale for coa...
Alternative Titles
Full title
Pharmacokinetics and tolerability of exemestane in combination with raloxifene in postmenopausal women with a history of breast cancer
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_212470893
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_212470893
Other Identifiers
ISSN
0167-6806
E-ISSN
1573-7217
DOI
10.1007/s10549-007-9787-1
